TempP(1)

cont as TempP(2)

32815099 2020. Repurposing calcium channel blockers as antiviral drugs.
32786695 2020. Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server.
32837097 2020. Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far.
32809969 2020. Baricitinib restrains the immune dysregulation in severe COVID-19 patients.
32751615 2020. A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era.
32727069 2020. A Cell-Based Reporter Assay for Screening Inhibitors of MERS Coronavirus RNA-Dependent RNA Polymerase Activity.
32726951 2020. Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis.
32872629 2020. Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
32858940 2020. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
32785135 2020. Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy.
32785121 2020. Key Aspects in Nutritional Management of COVID-19 Patients.
32849949 2020. Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19.
32849936 2020. Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
32849934 2020. Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review.
32779201 2020. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.
32741525 2020. Attenuating hyperinflammation in COVID-19: A change in paradigm?
32871418 2020. Intratracheal administration of autologus conditioned serum for COVID-19 associated respiratory distress syndrome.
32814271 2020. Inhaled nitric oxide in mechanically ventilated patients with COVID-19.
32827987 2020. The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients.
32885340 2020. The immune-modulatory effects of exercise should be favorably harnessed against COVID-19.
32772324 2020. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19.
32860209 2020. What we have to know about corticosteroids use during Sars-Cov-2 infection.
31724441 2020. Inhibition of SARS-CoV 3CL protease by flavonoids.
32678432 2020. Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
32754467 2020. COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?
32783247 2020. Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CL(pro) : An in silico approach with 19 structural different hydrolysable tannins.
32773258 2020. Therapeutic plasma exchange resolving COVID-19 related ARDS.
32834835 2020. Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus.
32837538 2020. Potential compound from herbal food of rhizoma polygonati for treatment of COVID-19 analyzed by network pharmacology and molecular docking technology.
32885373 2020. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
32692647 2020. A novel antiviral formulation inhibits a range of enveloped viruses.
32725286 2020. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
32777441 2020. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
32763357 2020. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
32828896 2020. A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Reunion Island.
32792611 2020. Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2.
32828791 2020. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
32784217 2020. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
32795481 2020. Impact of Routine Infant BCG Vaccination on COVID-19.
32794463 2020. A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries.
32726430 2020. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
32798222 2020. Plasma from recovered COVID-19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay.
32779705 2020. SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients.
32777038 2020. Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis.
32773212 2020. Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
32745348 2020. Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients.
32744399 2020. Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study.
32837113 2020. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
32784192 2020. Efficacy of Hydroxychloroquine and Tocilizumab in Patients With COVID-19: Single-Center Retrospective Chart Review.
32767684 2020. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
32749708 2020. Can aldosterone increase interleukin-6 levels in Covid-19 pneumonia?
32749702 2020. Targeting human TLRs to combat COVID-19: A solution?
32856721 2020. Tocilizumab - A beacon of hope in the management of severe COVID-19?
32841451 2020. Targeting NLRP3 Inflammasome in an Animal Model for SARS-CoV-2.
32833258 2020. Live unattenuated vaccines for controlling viral diseases including COVID-19.
32827313 2020. Convergence between global BCG vaccination and COVID-19 pandemic.
32813283 2020. Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis.
32808712 2020. Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials.
32790075 2020. Late onset infectious complications and safety of tocilizumab in the management of COVID-19.
32786041 2020. Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir.
32776573 2020. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
32776550 2020. Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted.
32776534 2020. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
32862236 2020. Entry Inhibitors: Efficient Means to Block Viral Infection.
32833058 2020. Various Facets of Pathogenic Lipids in Infectious Diseases: Exploring Virulent Lipid-Host Interactome and Their Druggability.
32627758 2020. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
32855060 2020. Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19 patient.
32829149 2020. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
32745925 2020. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CL(pro) of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches.
32739642 2020. Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.
32866780 2020. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2.
32861974 2020. Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2.
32863490 2020. Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins.
32839634 2020. Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation.
32834115 2021. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.
32863430 2021. Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors.
32834114 2020. Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2.
32808988 2020. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute COVID-19 in Pediatric Patients.
32764275 2020. Postulated Adjuvant Therapeutic Strategies for COVID-19.
32874702 2020. Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches.
32735768 2020. Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.
32829256 2020. Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking.
32855026 2020. Light-based technologies for management of COVID-19 pandemic crisis.
32790379 2020. Interdiction of Protein Folding for Therapeutic Drug Development in SARS CoV-2.
32787337 2020. Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2.
32787328 2020. Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies.
32770854 2020. Clinical trial to test the efficacy of melatonin in COVID-19.
32765615 2020. Glucocorticoids in COVID19; a friend not foe.
32871238 2020. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
32735992 2020. Design of an engineered ACE2 as a novel therapeutics against COVID-19.
32839756 2020. Azithromycin: The First Broad-spectrum Therapeutic.
32847594 2020. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
31703698 2019. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
32441826 2020. Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis.
31462558 2019. Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity.
31578288 2019. Small-Molecule Antiviral beta-d-N (4)-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.
32748578 2020. Interferon-alpha2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
32880651 2020. Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results.
32658285 2020. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
32789513 2020. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
32776022 2020. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
32833241 2020. Lessons Learned in Nutrition Therapy in Patients With Severe COVID-19.
32799322 2020. Challenges of Maintaining Optimal Nutrition Status in COVID-19 Patients in Intensive Care Settings.
32838087 2020. Acute kidney injury associated with lopinavir/ritonavir combined therapy in patients with Covid-19.
32869007 2020. Lopinavir-ritonavir associated acute kidney injury is not related to crystalluria in critically-ill COVID-19 patients.
32729620 2020. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
32798489 2020. COVID-19 combination prevention requires attention to structural drivers.
32798481 2020. COVID-19 trial co-enrolment and subsequent enrolment.
32758429 2020. Vitamin D for COVID-19: a case to answer?
32828171 2020. Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.
32835325 2020. Increasing accessibility in COVID-19 clinical trials.
32723801 2020. Drug Discovery Strategies for SARS-CoV-2.

32835332 2020. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma.
32738928 2020. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
32835653 2020. Apples and oranges: international comparisons of COVID-19 observational studies in ICUs.
32838317 2020. Effect of anakinra in COVID-19 - Authors' reply.
32838316 2020. Effect of anakinra in COVID-19.
32838323 2020. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
32838322 2020. The conundrum of interleukin-6 blockade in COVID-19.
32838321 2020. Anakinra for severe forms of COVID-19 - Authors' reply.
32838320 2020. Anakinra for severe forms of COVID-19.
32838319 2020. Anakinra for severe forms of COVID-19.
32838318 2020. Anakinra for severe forms of COVID-19.
32864627 2020. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
32838327 2020. Tocilizumab for severe COVID-19 pneumonia.
32838326 2020. Tocilizumab for severe COVID-19 pneumonia - Authors' reply.
32838325 2020. Tocilizumab for severe COVID-19 pneumonia.
32838324 2020. Tocilizumab for severe COVID-19 pneumonia.
32835256 2020. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
32879427 2020. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
32814839 2020. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
32784922 2020. A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review.
32777300 2020. Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
32750438 2020. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
32738360 2020. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
32846167 2020. Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
32841659 2020. GRP78 targeting: Hitting two birds with a stone.
32818545 2020. Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges.
32788852 2020. Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections.
32863755 2020. Ivermectin: Potential Role as Repurposed Drug for COVID-19.
32837243 2020. Cellular decoys distract coronavirus.
32829981 2020. Be well: A potential role for vitamin B in COVID-19.
32861345 2020. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids.
32861340 2020. Targeting TMPRSS2 in SARS-CoV-2 Infection.
32861333 2020. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.
32838206 2020. A narrative review of emerging therapeutics for COVID-19.
32820005 2020. GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.
32838354 2020. What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials.
32838355 2020. Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.
32838361 2020. Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.
32837137 2020. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery.
32838988 2020. Indicacion de los pulsos de glucocorticoides en pacientes con infeccion por SARS-CoV-2.
32873396 2020. Neumomediastino espontaneo en neumonitis por coronavirus evolucionada.
32778429 2020. Utilizacion de antisepticos orales para la infeccion por SARS-CoV-2.
32838043 2020. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
32835213 2020. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.
32763662 2020. A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19.
32763660 2020. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
32759016 2020. Estrogen shields women from COVID-19 complications by reducing ER stress.
32768893 2020. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.
32759013 2020. High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
32758904 2020. N-acetycysteine: A potential therapeutic agent in COVID-19 infection.
32759008 2020. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
32759007 2020. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.
32758903 2020. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
32758901 2020. Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
32721808 2020. Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.
32721806 2020. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
32758899 2020. BCG vaccination and COVID-19: Much ado about nothing?
32721805 2020. Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin.
32795835 2020. Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?
32795832 2020. Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19.
32852058 2020. The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
32838397 2020. Regulatory T cells: A potential weapon to combat COVID-19?
32658856 2020. Efectos adversos cardiacos de hidroxicloroquina y la necesidad de ensayos.
32658855 2020. Seguridad cardiovascular de la hidroxicloroquina en la pandemia de COVID-19.
32658853 2020. Uso de plasma de convalecientes para tratamiento de COVID-19. Historia y evidencia.
32658841 2020. Desarrollo de un suero equino hiperinmune para el tratamiento de COVID-19 en Argentina.
32752010 2020. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application.
32727107 2020. Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.
32825011 2020. Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
32756215 2020. Therapeutic response to corticosteroids in a critically ill patient with COVID-19: A case report.
32756149 2020. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report.
32791753 2020. A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019.
32791699 2020. The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.
32769922 2020. A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19.
32846825 2020. Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China.
32808940 2020. The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
32162250 2020. A Computational Vaccine Designing Approach for MERS-CoV Infections.
32835775 2020. Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19.
32818576 2020. The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
32878286 2020. Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids.
32825283 2020. Novel Antiviral Strategies in the Treatment of COVID-19: A Review.
32824639 2020. Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease.
32853546 2020. Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.
32877642 2020. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.
32880078 2020. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.
32737681 2020. Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
32750187 2020. Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking.
32808122 2020. Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.
32729248 2020. In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
32882868 2020. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
32784680 2020. Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions.
32872217 2020. Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19.
32867349 2020. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
32842509 2020. Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method.
32842606 2020. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
32824454 2020. Putative SARS-CoV-2 M(pro) Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study.
32836400 2020. Alte Medikamente in neuen Schuhen. Substanzen, die gegen COVID-19 (nicht) zum Einsatz kommen.
32763844 2020. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
32722908 2020. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
32825737 2020. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
32873192 2020. No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19.
32857226 2020. Nano-clays as Potential Pseudo-antibodies for COVID-19.
32855401 2020. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.
32848158 2020. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
32843628 2020. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.
32826924 2020. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.
32826914 2020. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
32796842 2020. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge.
32792628 2020. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.
32772313 2020. Anthraquinone Derivatives as an Immune Booster and their Therapeutic Option Against COVID-19.
32873977 2020. The COVID-19 pandemic: a catalyst to improve clinical trials.
32873887 2020. Inhaled nanobodies against COVID-19.

32807860 2020. A cocktail of antibodies for COVID-19 therapy.
32782354 2020. SARS-CoV-2 vaccine - think globally, act locally.
32778829 2020. After 62 years of regulating immunity, dexamethasone meets COVID-19.
32776624 2020. Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia.
32834922 2020. Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease.
32839670 2020. Hydroxychloroquine is protective to the heart, not harmful: a systematic review.
32864162 2020. Pharmacogenomics of COVID-19 therapies.
32793398 2020. Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.
32872374 2020. Antiviral Functional Foods and Exercise Lifestyle Prevention of Coronavirus.
32854262 2020. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
32847033 2020. Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.
32842513 2020. Could Vitamins Help in the Fight Against COVID-19?
32844132 2020. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection.
32817375 2020. Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
32837535 2020. What is the best mouthrinse against Coronaviruses?
32667665 2020. Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
32751194 2020. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.
32832263 2020. Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences.
32889022 2020. Peptides to combat viral infectious diseases.
32778962 2020. Repurposing of Kinase Inhibitors for Treatment of COVID-19.
32882888 2020. Zinc(II)-The Overlooked Eminence Grise of Chloroquine's Fight against COVID-19?
32784499 2020. Emerging Therapeutic Modalities against COVID-19.
32397649 2020. MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice.
32880878 2020. How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton.
32816200 2020. Pharmacological treatments of COVID-19.
32781283 2020. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
32866599 2020. Chinese herbal medicine supplementation therapy on COVID-19.
32791263 2020. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.
32715661 2020. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.
32763473 2020. Ultraviolet germicidal irradiation for filtering facepiece respirators disinfection to facilitate reuse during COVID-19 pandemic: A review.
32818638 2020. Photodynamic and Sonodynamic Therapy of Acute Hypoxemic Respiratory Failure in Patients with COVID-19.
32776317 2020. Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence.
32809918 2020. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
32639219 2020. Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.
32639181 2020. Consideration of Tranexamic Acid Administration to COVID-19 Patients.
32741697 2020. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.
32798019 2020. Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism.
32843234 2020. Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review.
32890913 2020. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-kappaB) signaling pathway.
32779813 2020. Rugosic acid A, derived from Rosa rugosa Thunb., is novel inhibitory agent for NF-kappaB and IL-6/STAT3 axis in acute lung injury model.
32754955 2020. Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy.
32748969 2020. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease.
32815574 2020. Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint.
32881214 2020. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
32785960 2020. Traditional and complementary medicine during COVID-19 pandemic.
32779305 2020. High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.
32798764 2020. Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment.
32836404 2020. Selenium biofortification in the 21(st) century: status and challenges for healthy human nutrition.
32837491 2020. Nonthermal plasma as part of a novel strategy for vaccination.
32881895 2020. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
32726304 2020. Developing a low-cost and accessible COVID-19 vaccine for global health.
32881982 2020. Observational study of azithromycin in hospitalized patients with COVID-19.
32817707 2020. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
32790733 2020. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
32785259 2020. Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease.
32749826 2020. Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis.
32855214 2020. Vitamin D status and outcomes for hospitalised older patients with COVID-19.
32848085 2020. Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures.
32778507 2020. COVID-19 and steroid therapy: Impact on diabetes.
32061635 2020. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
32761523 2020. Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.
32754890 2020. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
32871242 2020. Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
32735326 2020. Potential role of hypovitaminosis D and Vitamin D supplementation during COVID-19 pandemic.
32874905 2020. Dexamethasone in severe COVID-19 infection: A case series.
32868989 2020. Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD.
32759053 2020. A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.
32836663 2020. Melatonina, coronavirus, enfermedad cardiovascular y emergencia geriatrica: inverted exclamation markusemos todo lo que tenemos!
32768324 2020. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have! Response.
32779326 2020. Drugs against SARS-CoV-2: What do we know about their mode of action?
32880032 2020. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
32839635 2020. Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches.
32834516 2020. A phenomenological approach to assessing the effectiveness of COVID-19 related nonpharmaceutical interventions in Germany.
32813843 2020. Study of ongoing registered clinical trials on COVID-19: a narrative review.
32837217 2020. Potential mechanisms of Chinese Herbal Medicine that implicated in the treatment of COVID-19 related renal injury.
32868970 2020. Novel beta-Coronavirus (SARS-CoV-2): Current and Future Aspects of Pharmacological Treatments.
32797724 2020. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?
32773341 2020. Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
32761451 2020. Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs.
32876887 2020. Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.
32753646 2020. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
32868801 2020. Signal amplification by reversible exchange for COVID-19 antiviral drug candidates.
32807895 2020. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors.
32792492 2020. Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019.
31705137 2019. Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels.
23594967 2013. Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin.
32703908 2020. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
32855394 2020. Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery.
32855385 2020. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
32838178 2020. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19.
32838169 2020. Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.
32838168 2020. The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit.
32838182 2020. Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.
32838181 2020. Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results.
32864571 2020. Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective.
32838195 2020. Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection.
32838187 2020. Protease Inhibitor Use in COVID-19.
32866803 2020. Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer.
32811531 2020. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
32795359 2020. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
32748331 2020. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.
32839921 2020. Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives.
32827081 2020. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
32815107 2020. Epidermal Neural Crest Stem Cells as a Perspective for COVID-19 Treatment.
32789802 2020. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.
32740890 2020. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
32779878 2020. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
32856432 2020. Regen med therapeutic opportunities for fighting COVID-19.
32820868 2020. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective.
32808462 2020. Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19.
32816059 2020. Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review.
32837118 2020. Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy.

32761294 2020. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation.
32868999 2020. Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine.
32786284 2020. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
32743211 2020. Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase.
32821885 2020. Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection.
32821882 2020. Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm.
32818929 2020. Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies.
32791509 2020. G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?
32843715 2020. Cobrotoxin could be an effective therapeutic for COVID-19.
32747721 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
32737471 2020. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
32863556 2020. Covid-19, prise en charge, pistes therapeutiques et vaccinales.
32838213 2020. Rapid production of clinical-grade SARS-CoV-2 specific T cells.
32837893 2020. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review.
32837891 2020. The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
32837895 2020. Clinical significance summary: Preliminary results of a rapid review of zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections.
32837894 2020. The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
32837847 2020. A Randomized, Open-label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, A Pilot Study.
32858566 2020. Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
32852338 2020. Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.
32852340 2020. Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
32871003 2020. ASHP principles for COVID-19 vaccine distribution, allocation, and mass immunization.
32837119 2020. Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19.
32746913 2020. Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.
32868957 2020. Ultrasound assisted synthesis of 3-alkynyl substituted 2-chloroquinoxaline derivatives: Their in silico assessment as potential ligands for N-protein of SARS-CoV-2.
32834770 2020. Favipiravir tautomerism: a theoretical insight.
32821381 2020. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
32873175 2020. Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.
32865158 2020. COVID-19 and molecular hydrogen inhalation.
32865137 2020. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia.
32684095 2020. Worrying situation regarding the use of dexamethasone for COVID-19.
32778854 2020. COVID-19: should oral vaccination strategies be given more consideration?
32801727 2020. Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date.
32863947 2020. Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections.
32747475 2020. Tension pneumomediastinum in patients with COVID-19.
32662203 2020. Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2.
32815655 2020. Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
32888822 2020. Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report.
32713627 2020. Convalescent plasma for covid19 - How long should a donor be excluded from donation?
32878733 2020. Convalescent plasma for COVID-19 considerations.
32883594 2020. The successful management of an elderly Covid-19 infected patient by plasmapheresis.
32883593 2020. SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma.
32771272 2020. A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence).
32770691 2020. Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19.
32748963 2020. Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network.
32840002 2020. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
32798271 2020. Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4 degrees Celsius for at least 6 weeks.
32889105 2020. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
32739472 2020. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
32791213 2020. Dexamethasone: A boon for critically ill COVID-19 patients?
32836826 2020. Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data.
32711925 2020. Can Activation of NRF2 Be a Strategy against COVID-19?
32883328 2020. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
32868985 2020. Correlation between immunity from BCG and the morbidity and mortality of COVID-19.
32883062 2020. COVID-19 death and BCG vaccination programs worldwide.
32832735 2020. Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment.
32702948 2020. Hydroxychloroquine-associated Thrombotic Thrombocytopenic Purpura.
32718128 2020. Perspectives for the immune plasma treatment of COVID-19.
32777902 2020. Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?
32776230 2020. Kann Androgendeprivationstherapie eine protektive Rolle bei SARS-CoV-2-Infektionen spielen?
32863070 2020. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
32798142 2020. The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
32875286 2020. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
32471056 2020. The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation.
32429204 2020. Pustulan Activates Chicken Bone Marrow-Derived Dendritic Cells In Vitro and Promotes Ex Vivo CD4(+) T Cell Recall Response to Infectious Bronchitis Virus.
32731461 2020. Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach.
32717854 2020. Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease-Paving the Way for Vaccine Development.
32707833 2020. COVID-19: Mechanisms of Vaccination and Immunity.
32781672 2020. SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.
32781571 2020. Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies.
32872186 2020. Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?
32867098 2020. Vaccines against RNA Viruses.
32854391 2020. Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2.
32846910 2020. A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.
32865701 2020. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study.
32882638 2020. Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
32768490 2020. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.
32717346 2020. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
32866534 2020. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
32866536 2020. Association of vitamin D with the modulation of the disease severity in COVID-19.
32846196 2020. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
32827627 2020. Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
32800805 2020. COVID-19 Vaccine: A comprehensive status report.
31560964 2019. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.
32722574 2020. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
32674326 2020. Temperature Sensitivity: A Potential Method for the Generation of Vaccines against the Avian Coronavirus Infectious Bronchitis Virus.
31968702 2020. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.
32784685 2020. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
32859008 2020. Optimization Rules for SARS-CoV-2 M(pro) Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.
32726230 2020. Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.
32726238 2020. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
32734479 2020. Partially ionized medical oxygen as a supplementary treatment for COVID-19.
32776298 2020. Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort.
32837110 2020. 42 cases of coronavirus disease 2019 of the ordinary type with the adjuvant treatment of heat-sensitive moxibustion 42.
32837109 2020. Case of professor Xu ZOU's acupuncture technique for "benefiting kidney and strengthening anti-pathogenic qi" in promoting the absorption of COVID-19.
32837108 2020. Two cases of corona virus disease 2019 (COVID-19) treated with the combination of acupuncture and medication in bedridden patients2.
32837107 2020. Thoughts on the effects of moxa smoke in the epidemic prevention.
32742564 2020. Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.
32832877 2020. Polymonoclonal (Not Polyclonal) Antibodies Derived from Convalescent Human B Cell Hybridomas Might Be a Better Therapeutic Option than Single Target Monoclonal Antibodies.
32726783 2020. JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients.
31955138 2020. Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
32551793 2020. Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus.
32761570 2020. Epithelial Dysfunction in Lung Diseases: Effects of Amino Acids and Potential Mechanisms.
32875709 2020. Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo.
32864794 2020. Particulate Alum via Pickering Emulsion for an Enhanced COVID-19 Vaccine Adjuvant.
32726479 2020. Bacillus Calmette-Guerin vaccination and socioeconomic variables vs COVID-19 global features: Clearing up a controversial issue.
32827405 2020. Are Medicinal Plants an Alternative Strategy to Combat COVID-19?
32827400 2020. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
32845250 2020. COVID-19: Prospective Challenges and Potential Vaccines.
32668969 2020. Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.
32839815 2020. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
32631576 2020. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.

32805728 2020. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19.
32876941 2020. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients.
32865757 2020. Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy.
32797388 2020. Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak.
32765941 2020. Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.
32765939 2020. COVID-19 and Senotherapeutics: Any Role for the Naturally-occurring Dipeptide Carnosine?
32765938 2020. Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19.
32656827 2020. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
32762135 2020. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19.
32774998 2020. Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection.
32737841 2020. Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
32804917 2020. Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.
32865522 2020. A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19.
32796809 2020. Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report.
32616373 2020. The influence of corticosteroid on patients with COVID-19 infection: A meta-analysis.
32795424 2020. Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.
32755302 2020. Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?
32787704 2020. Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?
32672049 2020. Reply to Jakovac: COVID-19, vitamin D, and type I interferon.
32778354 2020. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.
32841477 2020. Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays.
32878641 2020. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
32805515 2020. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
32866405 2020. Web Exclusive. Annals On Call - Regulatory T Cells: Treatment for COVID-19?
32730105 2020. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
32853033 2020. Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
32737995 2020. Reply to the Letter "COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation".
32822832 2020. Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy.
32787379 2020. Overview of prognostic factors in adult gliomas
32819125 2020. Epidemiology and clinical characteristics of 43 COVID-19 patients in Weifang, China.
32787373 2020. Modified rehabilitation exercises for mild cases of COVID-19.
32863659 2020. Patterns of myocardial involvement in children during COVID-19 pandemic: Early experience from northern Italy.
32719045 2020. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
32732245 2020. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
32855151 2020. Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al.
32831940 2020. Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
32831932 2020. Amphotericin B as antiviral drug: Possible efficacy against COVID-19.
32890967 2020. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
32761219 2020. Convalescent plasma to treat COVID-19.
32790855 2020. Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
32889088 2020. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.
32881062 2020. Hypothesis: The Potential Therapeutic Role of Nicorandil in COVID-19.
32881059 2020. A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion.
32857836 2020. Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers.
32845289 2020. Methylprednisolone for COVID-19: Was Benjamin Rush prescient?
32829400 2020. BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden.
32869854 2020. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.
32622469 2020. Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
32750259 2020. COVID-19: Clean up on IL-6.
32857620 2020. Azithromycin Downregulates Gene Expression of IL-1beta and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2.
32853024 2020. Immune Modulation to Improve Survival of Viral Pneumonia in Mice.
32755507 2020. Rewiring the Immune Response in COVID-19.
32886840 2020. Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation.
32870563 2020. Catalytic Asymmetric Synthesis of the Anti-COVID-19 Drug Remdesivir.
32729180 2020. Molecular Insights into Small Molecule Drug Discovery for SARS-CoV-2.
32864982 2020. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19.
32735169 2020. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
32581018 2020. Could Demodex Be Used to Augment a Topical Vaccine Against Coronavirus (and Similar Viruses)?
32737112 2020. Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.
32737108 2020. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.
32737107 2020. More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia.
32737106 2020. Rational use of tocilizumab in COVID-19.
32737105 2020. Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli.
32759263 2020. Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis.
32753421 2020. Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci et al.
32753417 2020. Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al.
32855152 2020. Colchicine treatment in community healthcare setting to prevent severe COVID-19.
32816702 2020. Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang.
32816701 2020. High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab.
32816700 2020. Response to: 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini et al.
32816698 2020. Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al.
32759267 2020. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.
32868327 2020. Removal of remdesivir's metabolite GS-441524 by hemodialysis in a double lung transplant recipient with COVID-19.
32744511 2020. Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system.
32538803 2020. Implementacion de la teleconsulta en la practica urologica durante la era Covid-19: inverted question markque hemos aprendido?
32725790 2020. Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors?
32882061 2020. Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?
32701630 2020. Treatment of Cytokine Storm in COVID-19 Patients with Immunomodulatory Therapy.
32740071 2020. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
32740070 2020. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
32887677 2020. Covid-19: Hydrocortisone can be used as alternative to dexamethasone, review finds.
32732352 2020. Remdesivir for severe covid-19: a clinical practice guideline.
32759299 2020. Covid-19: Where are we on immunity and vaccines?
32843352 2020. Include pregnant women in research-particularly covid-19 research.
32843328 2020. Covid-19: US approves emergency use of convalescent plasma despite warnings over lack of evidence.
32839191 2020. Russian SARS-CoV-2 vaccine.
32816760 2020. The rush to create a covid-19 vaccine may do more harm than good.
32816758 2020. Covid-19: Russia approves vaccine without large scale testing or published results.
32881064 2020. Beyond Dexamethasone, Emerging Immuno-Thrombotic Therapies for COVID-19.
32820554 2020. Prescribing in COVID-19 patients: Should we take into account inflammation?
32758306 2020. Selenium and viral infection: are there lessons for COVID-19?
32843118 2020. Nutritional status, diet and viral respiratory infections: perspectives for SARS-CoV-2.
32815493 2020. Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective.
32656343 2020. Cannabinoids and the Coronavirus.
32769401 2020. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
32773440 2020. A Review of Remdesivir for COVID-19: Data to Date.
32745524 2020. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
32886768 2020. Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment?
32886762 2020. Efficacy of Tocilizumab for treatment of severe COVID-19 Pneumonia: more evidence is needed.
32674139 2020. The Value of Human Challenges in SARS-2-nCoV Vaccine Development.
32863274 2020. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
32863273 2020. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
32859332 2020. Easy-to-prescribe nutrition support in the intensive care in the era of COVID-19.
32881661 2020. Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach.
32748740 2020. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening.
32723229 2020. Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?
32767929 2020. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
32838713 2020. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking.
32819226 2020. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation.
32807047 2020. Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies.
32798373 2020. Molecular Docking and Virtual Screening based prediction of drugs for COVID-19.
32769050 2020. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.

32793725 2020. Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis.
31690009 2019. Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV.
32722164 2020. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity.
32823497 2020. Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits.
32739404 2020. The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
31863793 2020. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
31765674 2020. Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease.
32763313 2020. Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses.
32854147 2020. Can a gluten-free diet be partly protective for covid-19 infection?
32813067 2020. Construction of an infectious bronchitis virus vaccine strain carrying chimeric S1 gene of a virulent isolate and its pathogenicity analysis.
32813065 2020. Role of probiotics to combat viral infections with emphasis on COVID-19.
32836625 2020. Quantum dots as a promising agent to combat COVID-19.
32733978 2020. How to Boost our Immune System Against Coronavirus Infection?
32837201 2020. Inefficacite et dangerosite potentielle de l'hydroxychloroquine pour traiter une infection par le coronavirus Sars-cov2.
32723524 2020. Response to: Amantadine, COVID-19 and Parkinsonism.
32863034 2020. A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
32818235 2020. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers.
32740801 2020. Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.
32808185 2020. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
31950289 2020. Recombinant adenovirus carrying a core neutralizing epitope of porcine epidemic diarrhea virus and heat-labile enterotoxin B of Escherichia coli as a mucosal vaccine.
32253616 2020. A flagellin-adjuvanted inactivated porcine epidemic diarrhea virus (PEDV) vaccine provides enhanced immune protection against PEDV challenge in piglets.
32741139 2020. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis.
32779737 2020. The absorbing filter Oxiris in severe COVID-19 patients: A case series.
32674226 2020. Covid-19 and dietary socioecology: Risk minimisation.
32828312 2020. Establishment and validation of a drug-target microarray for SARS-CoV-2.
32592721 2020. Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na(+)/K(+)-ATPase independent proteolysise.
32739342 2020. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials.
32786401 2020. A Chemoenzymatic Synthesis of the (RP)-Isomer of the Antiviral Prodrug Remdesivir.
32805303 2020. Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
32743022 2020. Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?
32815593 2020. Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
32793443 2020. Computational-based drug repurposing methods in COVID-19.
32683439 2020. protein-sol pKa: prediction of electrostatic frustration, with application to coronaviruses.
32831527 2020. Views on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al. (2020).
32831526 2020. Comments on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al.(2020).
32831523 2020. Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease.
32831522 2020. Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease.
32831518 2020. Towards the design of epitope candidates for Coronavirus 2.
32773989 2020. Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.
32878881 2020. Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2.
32754003 2020. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review.
32731331 2020. The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections.
32846906 2020. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
32792167 2020. Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19).
32763818 2020. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
32736237 2020. Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
32861965 2020. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
32881296 2020. A Cytometrist's Guide to Coordinating and Performing Effective COVID-19 Research.
32882643 2020. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.
32889063 2020. Could PROTACs Protect Us From COVID-19?
32880807 2020. Comment on: "Pharmaco-Immunomodulatory Therapy in COVID-19".
32880806 2020. Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19".
32882216 2020. The prophylaxis and treatment potential of supplements for COVID-19.
32829416 2020. The Case for Re-Examining Glycosylation Inhibitors, Mimetics, Primers and Glycosylation Decoys as Antivirals and Anti-Inflammatories in COVID19.
32870053 2020. Comment on "Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic."
32888379 2020. Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs.
32881359 2020. Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-label Randomized Controlled Pilot Study.
32881340 2020. The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study.
32815389 2020. A concern about survival time as an endpoint in coronavirus disease 2019 clinical trials.
32815379 2020. COVID-19 impact on multi-site recruitment and enrollment.
32833695 2020. Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection.
32833772 2020. Therapeutic Options for the Treatment of Coronavirus Disease (COVID-19).
32860358 2020. Nanocarriers in the delivery of hydroxychloroquine to the respiratory system: An alternative to COVID-19?
32867652 2020. Feasibility of mesenchymal stem cell therapy for COVID-19:A mini review.
32881656 2020. Targeting COVID-19 in Parkinson's patients: Drugs repurposed.
32693756 2020. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.
32867666 2020. COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.
32767920 2020. The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review.
32867651 2020. Repositioning of drugs to counter COVID-19 pandemic - An Insight.
32881659 2020. Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.
32867645 2020. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach.
32787748 2020. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the "Cytokine Release (Storm) Syndrome" Caused by SARS-CoV-2?
32729428 2020. The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19.
32729640 2020. Probing 3CL protease: Rationally designed chemical moieties for COVID-19.
32877948 2020. The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences.
32875990 2020. Exploitation of some natural products for prevention and/or nutritional treatment of SARS-CoV2 infection.
32755992 2020. MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19.
32886952 2020. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
32739174 2020. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
32295404 2020. Amiodarone as a possible therapy for coronavirus infection.
32633332 2020. The complement inhibitors in COVID-19: future expectations.
32744716 2020. SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential.
32744711 2020. Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.
32767353 2020. Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy.
32767349 2020. Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.
32767348 2020. Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?
32767316 2020. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
32866053 2020. The effect of drugs used in rheumatology for treating SARS-CoV2 infection.
32744917 2020. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
32820694 2020. Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine-promising therapeutic strategy for SARS-CoV-2 treatment.
32877233 2020. A public-private partnership for the express development of antiviral leads: a perspective view.
32840116 2020. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?
32799566 2020. Emerging therapeutics for the management of COVID 19.
32752970 2020. The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications.
32887532 2020. Inhibitors of Type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
32814446 2020. COVID-19: fighting the invisible enemy with microRNAs.
32853038 2020. Azithromycin in the treatment of COVID-19: a review.
32809870 2020. MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.
32795214 2020. Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches.
32746653 2020. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
32729363 2020. Development and progress of clinical trials of Coronavirus Disease 2019 antiviral drugs.
32734777 2020. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
32815406 2020. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach.
32842811 2020. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
32869699 2020. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
32838605 2020. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
32776374 2020. AMPK activation by ozone therapy inhibits tissue factor-triggered intestinal ischemia and ameliorates chemotherapeutic enteritis.
32831340 2020. Optimizacion de la terapia nutricional en el paciente critico con COVID-19.
32831329 2020. COVID-19 y la nutricion clinica. inverted question markPor que es importante?
32745502 2020. Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
32536610 2020. Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.
32742008 2020. Repurposed Drugs Against COVID-19: Safety Concerns and Stockout.

32846329 2020. Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.
32768882 2020. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
32781796 2020. Arginine and Endothelial Function.
32126736 2020. Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.
32825327 2020. Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease.
32796765 2020. Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101).
31690059 2019. Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells.
32781216 2020. Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors.
31624041 2019. Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors.
32718376 2020. Clozapine and COVID-19.
32340021 2020. Early Leukapheresis Depletion in an Ex-Premature with Severe Acute Respiratory Distress Syndrome Due to Bordetella Pertussis and Coronavirus Infection.
32854985 2020. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
32731913 2020. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
32807087 2020. Improving the impact of non-pharmaceutical interventions during COVID-19: examining the factors that influence engagement and the impact on individuals.
32867708 2020. Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients.
32819292 2020. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19).
32883368 2020. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
32732190 2020. Drug treatments for covid-19: living systematic review and network meta-analysis.
32764129 2020. Patient-centric research in the time of COVID-19: conducting ethical COVID-19 research in Africa.
32816957 2020. Bowel ulceration following tocilizumab administration in a COVID-19 patient.
32818151 2020. Virucidal benefits of povidone-iodine use on the ocular surface: a review.
32792138 2020. A novel role for lidocaine in COVID-19 patients?
32779815 2020. Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.
32730151 2020. Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
32859459 2020. Use of mouthwashes against COVID-19 in dentistry.
32783196 2020. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2 S donors in COVID-19 therapy.
32757447 2020. COVID-19 and gastrointestinal symptoms.
32883935 2020. Genomic evolution of severe acute respiratory syndrome Coronavirus 2 in India and vaccine impact.
32859863 2020. Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
32811798 2020. Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
32773415 2020. Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
32773410 2020. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
32880819 2020. Vaccine Against Covid-19 Disease - Present Status of Development.
32882432 2020. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine.
32889241 2020. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
32889236 2020. Outcome of COVID-19 patients with use of Tocilizumab: A single center experience.
32829390 2020. Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU.
32880390 2020. Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China.
32881641 2020. Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19.
32880510 2020. Intravescical instillation of Calmette-Guerin bacillus and COVID-19 risk.
32762516 2020. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
32845742 2020. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
32883116 2020. Future perspective: biologic agents in patients with severe COVID-19.
32871847 2020. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
32871846 2020. Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.
32801224 2020. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
32644027 2020. Tocilizumab for COVID-19: a real 'miracle drug'?
32866084 2020. Preliminary study on relationships among nutritional risk, serum prealbumin, and peripheral blood T cell subsets in patients with severe COVID-19.
32789663 2020. Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19.
32718300 2020. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
32696730 2020. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
32758675 2020. Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine.
32862840 2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
32729823 2020. Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient.
32787470 2020. Probiotics and Covid-19.
32886632 2020. Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients.
32718410 2020. Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
32744166 2020. Is vitamin C an effective agent for the prevention of COVID-19 and treatment of severe infection in the ICU?
32811354 2020. Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects.
32740371 2020. Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients.
32870735 2020. Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.
32795138 2020. Vitamin D and Wellbeing beyond Infections: COVID-19 and Future Pandemics.
32722759 2020. Value of Tenets of Osteopathic Medicine for Patients During COVID-19 Crisis.
32776139 2020. Osteopathic Considerations for the Pregnant Patient with COVID-19.
32888000 2020. Comment on: Favipiravir, an antiviral for COVID-19?
32812051 2020. The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
32610879 2020. Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?
32610873 2020. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
32610872 2020. Research and Ethics during the COVID-19 Pandemic.
32738852 2020. Hydroxychloroquin for COVID-19 Why was so much hype?
32727845 2020. Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naive semisynthetic library.
32885740 2020. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study.
32876538 2020. Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases.
32875950 2020. Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL(pro) of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics.
32873185 2020. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M(pro).
32873176 2020. Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses.
32734828 2020. Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations.
32729392 2020. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19.
32762537 2020. In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins.
32762511 2020. In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach.
32762411 2020. Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches.
32752951 2020. Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.
32752947 2020. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
32752944 2020. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.
32752938 2020. In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.
32741322 2020. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
32741312 2020. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
32741259 2020. Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.
32851919 2020. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study.
32851912 2020. In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.
32838660 2020. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
32835632 2020. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
32815796 2020. Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis.
32815481 2020. Molecular docking and simulation studies on SARS-CoV-2 M(pro) reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19.
32811367 2020. An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease.
32799761 2020. In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening.
32795148 2020. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M(pro)) through docking, molecular mechanic & dynamic, and ADMET profiling.
32783586 2020. New anti-viral drugs for the treatment of COVID-19 instead of favipiravir.
32772895 2020. Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study.
32772892 2020. In silico designing of multi-epitope vaccine construct against human coronavirus infections.
32740262 2020. Understanding COVID-19 Vaccines and Their Development.
32870576 2020. QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights.
32864768 2020. Reply to: "QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights".
32740445 2020. An expression of concern on research during the Covid-19 pandemic.
32740441 2020. Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemia.
32858645 2020. Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog.
32785687 2020. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.
32794180 2020. IL-18 and infections: Is there a role for targeted therapies?
32853525 2020. Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 M(pro).
32233478 2020. Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation.
32875601 2020. Therapeutic plasma exchange in a critically ill Covid-19 patient.
32833728 2020. Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.

31776599 2020. Entwicklung von Impfstoffen gegen neu auftretende Infektionskrankheiten mit epidemischem Potenzial.
32844112 2020. Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19.
32805774 2020. RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19.
32686633 2020. QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
32870433 2020. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.
32734502 2020. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.
32802540 2020. Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient.
32835086 2020. Effect of oral l-Glutamine supplementation on Covid-19 treatment.
32829986 2020. Personal View: Low-Dose Lung Radiotherapy Should be Evaluated as a Treatment for Severe COVID-19 Lung Disease.
32876748 2020. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2.
32725382 2020. Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
32856282 2020. Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.
32767755 2020. Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2.
32804426 2020. Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy.
32702224 2020. Clozapine in the Time of COVID-19.
32728438 2020. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019.
32799423 2020. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
32876108 2020. The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19.
32828069 2020. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
32828990 2020. The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target.
32868983 2020. Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.
32654163 2020. First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
32887650 2020. Treatment with angiotensin II in COVID-19 patients may not be beneficial.
32718345 2020. Inhibiting IL-6 in COVID-19: we are not sure.
32771054 2020. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study.
32753056 2020. Plasma exchange in critically ill COVID-19 patients.
32859243 2020. Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?
32859242 2020. Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!
32854738 2020. Efficacy of tocilizumab treatment in severely ill COVID-19 patients.
32847620 2020. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
32819415 2020. Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19.
32811550 2020. Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors.
32807220 2020. Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia.
32792018 2020. High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection.
32787901 2020. Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients.
32671349 2020. Evidence of Steroids in Patients With Acute Respiratory Distress Syndrome in Coronavirus Disease 2019.
32832913 2020. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.
32766569 2020. Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter.
32804792 2020. Core Outcomes Set for Trials in People With Coronavirus Disease 2019.
32804789 2020. International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019.
32754408 2020. The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts.
32754388 2020. Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts.
32699671 2020. Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
32685300 2020. The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series.
32818119 2020. Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series.
32789088 2020. Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review.
32802622 2020. Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York.
32823144 2020. The host targeting effect of chloroquine in malaria.
32837854 2020. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
32837853 2020. Colchicine in COVID-19: an Old Drug, New Use.
32864299 2020. Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.
32863400 2020. Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies.
32822911 2020. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.
32882269 2020. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
32746637 2020. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
32888840 2020. Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics.
32888976 2020. Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
32844224 2020. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
32889701 2020. Drug repurposing approach to fight COVID-19.
32764148 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
32860252 2020. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
32723468 2020. Convalescent Plasma: Promise for COVID-19 Pandemic.
32723461 2020. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
32763058 2020. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study.
32875925 2020. Active-site Molecular docking of Nigellidine with nucleocapsid- NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats.
32870539 2020. Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
32821033 2020. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
32804611 2020. Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.
32887991 2020. Immunosenescence and SARS-CoV-2 Vaccine Development.
32845317 2020. Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
32845303 2020. Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues.
32792254 2020. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.
32881593 2020. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
32790488 2020. A Geroscience Approach to Preventing Pathologic Consequences of COVID-19.
32845145 2020. Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
32816615 2020. Could Sumac Be Effective on COVID-19 Treatment?
32886358 2020. Tolerability of Favipiravir therapy in critically-ill patients with COVID-19: a report of 4 cases.
32881014 2020. Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
32881007 2020. Are the steroids a blanket solution for COVID-19? a systematic review and meta-analysis.
32729947 2020. Could an acute respiratory distress syndrome in COVID-19 infected patients be calmed down simply by iron withdrawal from lung tissues?
32860432 2020. Tocilizumab use in COVID -19 associated pneumonia.
32860431 2020. Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
32711596 2020. Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
32504017 2020. India expands use of controversial drug for coronavirus despite safety concerns.
32731258 2020. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
32731257 2020. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
32726802 2020. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
32756549 2020. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
32785213 2020. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults.
32820261 2020. Evidence lags behind excitement over blood plasma as a coronavirus treatment.
32812005 2020. How we accelerated clinical trials in the age of coronavirus.
32782400 2020. Russia's fast-track coronavirus vaccine draws outrage over safety.
32698192 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
32749808 2020. Hydroxychloroquine en chloroquine bij COVID-19.
32839298 2020. Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
32796470 2020. A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.
32738510 2020. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
32769659 2020. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
32852324 2020. High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19).
32757981 2020. In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19.
32857671 2020. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
32833598 2020. Turning Up the Volume for Precision Herbal Medicine in Africa in an Era of COVID-19 and Planetary Biodiversity Loss.
32885904 2020. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
32814341 2020. COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg.
32758635 2020. COVID-19: Pharmacology and kinetics of viral clearance.
32758336 2020. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guerin vaccine: a case study of beta cells regeneration.
32800699 2020. The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis.
32248575 2020. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
32820084 2020. COVID-19 and the burning issue of drug interaction: never forget the ECG.
32817576 2020. Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19.
32788309 2020. Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter.
32868447 2020. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.

32734518 2020. Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection.
32857301 2020. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
32812187 2020. Is there any potential management against COVID-19? A systematic review and meta-analysis.
32803688 2020. The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19.
32772478 2020. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.
32740972 2020. Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
32750451 2020. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
32755836 2020. Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges.
32868092 2020. COVID-19: Therapeutics and interventions currently under consideration.
32868978 2020. Unethical not to Investigate Radiotherapy for COVID-19.
32855629 2020. Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China.
32748035 2020. Nanotechnology-based antiviral therapeutics.
32821086 2020. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
32801640 2020. Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients.
32753842 2020. Plasmapheresis, Anti-ACE2 and Anti-FcgammaRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19.
32779824 2020. Volatile molecules for COVID-19: A possible pharmacological strategy?
32770567 2020. Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
32761647 2020. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
32669523 2020. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
32669519 2020. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
32777537 2020. Global clinical trial mobilization for COVID-19: higher, faster, stronger.
32801052 2020. Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites.
32006468 2020. Recent discovery and development of inhibitors targeting coronaviruses.
32443163 2020. Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta.
32870481 2020. Remdesivir: First Approval.
32742294 2020. Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
32853989 2020. Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients.
32807701 2020. Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges.
32766547 2020. A vaccine for SARS-CoV-2: goals and promises.
32838238 2020. A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-kappa plus TFF2 in patients with moderate COVID-19.
32838235 2020. Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up.
32876089 2020. Mesenchymal stem cells in the treatment of coronavirus-induced pneumonia (COVID-19).
32845033 2020. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
32753375 2020. BET 1: The role of remdesivir in COVID-19 infection.
32795143 2020. Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study.
29907366 2019. Uso de ribavirina en virus distintos de la hepatitis C. Una revision de la evidencia.
32875809 2020. Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.
32379307 2020. Statin therapy and SAR-COV-2: an available and potential therapy?
32885275 2020. Molecular mechanisms involved in the positive effects of physical activity on coping with COVID-19.
32735689 2020. Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection.
32810285 2020. Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
32856202 2020. A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort.
32870381 2020. Reply: Iron chelation may harm patients with COVID-19.
32870380 2020. Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19.
32870379 2020. Iron chelation may harm patients with COVID-19.
32780229 2020. Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
32780273 2020. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
32501408 2020. Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?
32819797 2020. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
32859477 2020. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.
32771797 2020. Potential treatment methods targeting 2019-nCoV infection.
32810751 2020. The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020.
32871342 2020. Azithromycin: The First Broad-spectrum Therapeutic.
32798789 2020. Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds.
32854774 2020. How to follow-up a patient who received tocilizumab in severe COVID-19: a case report.
32851419 2020. Vitamin D and COVID-19 infection and mortality in UK Biobank.
32730844 2020. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
32827661 2020. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
32777212 2020. What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results.
32768505 2020. COVID-19: A review of the proposed pharmacological treatments.
32768503 2020. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
32763302 2020. Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective.
32763298 2020. Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
32758569 2020. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
32841640 2020. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19.
32841639 2020. Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2.
32828741 2020. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.
32750366 2020. An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment.
32802131 2020. Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia.
32845978 2020. Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure.
32814539 2020. Is ocular toxicity expected in chloroquine/hydroxychloroquine prescription as a therapeutic or prophylactic option in COVID-19?
32319447 2020. Viramina D e coronavirus: un nuovo campo di impiego?
32856339 2020. Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions.
32876224 2020. Agentes potencialmente terapeuticos contra el SARS-CoV-2: revision rapida de la evidencia.
32880317 2020. COVID-19: Convalescent plasma as a potential therapy.
32880303 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
32657706 2020. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
32847369 2020. Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.
32875611 2020. SARS-CoV-2 And Trojan Horse Phenomenon -Caveat In Vaccine Quest?
32747425 2020. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
32883851 2020. A molecular trap against COVID-19.
32732280 2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
32631874 2020. The line starts to form for a coronavirus vaccine.
32739134 2020. Tratamiento farmacologico en tiempos de incertidumbre: uso de la hidroxicloroquina/cloroquina en el tratamiento de COVID-19.
32790618 2020. Drugs Repositioned for COVID-19 Are Routinely Prescribed by Dermatologists.
32692266 2020. Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status.
32804597 2020. Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and Prolixin(RX) (Fluphenazine) Provides Off-Label Drug Candidates.
32710694 2020. Potential limitations of plasmapheresis in treatment of COVID-19 patients: How to overcome them?
32757745 2020. Gold nanoparticles against respiratory diseases: oncogenic and viral pathogens review.
32829936 2020. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
32773244 2020. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
32684497 2020. Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.
32448096 2020. Immunization with porcine epidemic diarrhea virus harbouring Fc domain of IgG enhances antibody production in pigs.
32857679 2020. Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection?
32759459 2020. Hydroxychloroquine is no miracle cure for covid-19 infection -imaging and clinical course in an elderly female.
32696759 2020. [Discussion and prospect of infusion of NK cells in the treatment of SARS-CoV-2 infection].
32762168 2020. [Nutritional support for critically ill patients with COVID-19].
32648389 2020. [Exploration of fire needling therapy on coronavirus disease 2019].
32869585 2020. [Discussion on the effect pathways of preventing and treating coronavirus disease 2019 by acupuncture and moxibustion from the regulation of immune inflammatory response].
32726008 2020. [Analysis of potential role of Chinese classic prescriptions in treatment of COVID-19 based on TCMATCOV platform].
32726007 2020. [Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].
32726006 2020. [Analysis on formula of Mongolian medicine for prevention of COVID-19].
32726005 2020. [Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].
32726004 2020. [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
32726003 2020. [Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
32489026 2020. [Intervention mechanism of Qingwen Baidu Yin on cytokine storm based on network pharmacology].
32385989 2020. [Glucocorticoid for coronavirus disease 2019: a dilemma].
32684211 2020. [A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation].
32684209 2020. [Meta-analysis of single-group rate of the distribution of traditional Chinese medicine syndromes in 2 139 patients with coronavirus disease 2019].
32684207 2020. [Exploration on the therapeutic mechanisms and safety of blood components of convalescents without erythrocytes on severe acute respiratory syndrome and coronavirus disease 2019].
32684206 2020. [Application of convalescent plasma for the treatment of adult patients with coronavirus disease 2019].
32684205 2020. [Expert opinion on diagnosis and treatment of coronavirus disease 2019 with traditional Chinese medicine based on "three syndromes and three methods"].

32779213 2020. COVID-19 and Vitamin D: A lesson from the skin.
32782493 2020. Repurposing current therapeutic regimens against SARS-CoV-2 (Review).
32783643 2020. Host-directed therapies: a potential solution to combat COVID-19.
32762581 2020. Immunotherapy for SARS-CoV-2: potential opportunities.
32850116 2020. Development of vaccines for SARS-CoV-2.
32802318 2020. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
32765844 2020. In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19.
32742639 2020. Turning up the heat on COVID-19: heat as a therapeutic intervention.
32704354 2020. Coronavirus disease 2019 drug discovery through molecular docking.
32704352 2020. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.
32780893 2020. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.
32760352 2020. COVID-19 and Diabetes: The Importance of Controlling RAGE.
32849658 2020. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
32849655 2020. Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung.
32849647 2020. Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
32849643 2020. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
32849619 2020. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
32793246 2020. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
32793245 2020. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
32760409 2020. Could the Induction of Trained Immunity by beta-Glucan Serve as a Defense Against COVID-19?
32760408 2020. Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories.
32760407 2020. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
32754165 2020. A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection.
32754164 2020. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis.
32754161 2020. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach.
32754160 2020. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
32733489 2020. Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option.
32733488 2020. Potential Fast COVID-19 Containment With Trehalose.
32719685 2020. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.
32719684 2020. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
32719683 2020. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.
32761491 2020. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.
32850924 2020. Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.
32850922 2020. Treatment Options for COVID-19: A Review.
32850921 2020. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
32850920 2020. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19.
32850918 2020. Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic.
32850916 2020. Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion.
32766266 2020. Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.
32733907 2020. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19.
32714936 2020. Aging and Coronavirus: Exploring Complementary Therapies to Avoid Inflammatory Overload.
32849448 2020. Directly Acting Antivirals for COVID-19: Where Do We Stand?
32793181 2020. Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis.
32765482 2020. Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review.
32754147 2020. Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro.
32850978 2020. Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.
32850973 2020. A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment.
32850963 2020. Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.
32850428 2020. On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents.
32848802 2020. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.
32848795 2020. COVID-19 Therapeutic Options Under Investigation.
32848790 2020. Medicinal Plants as Sources of Active Molecules Against COVID-19.
32848788 2020. DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
32848776 2020. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.
32848774 2020. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
32848769 2020. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
32848765 2020. Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients.
32848729 2020. Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.
32792942 2020. Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of I K(M) or I K(DR) and in the Stimulation of I MEP.
32765279 2020. Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?
32765274 2020. No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study.
32765270 2020. The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection.
32754036 2020. BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
32574233 2020. Small Molecule Inhibitors of CRM1.
32848845 2020. Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome.
32719619 2020. While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?
32754571 2020. Novel Coronavirus Pneumonia Treatment With Traditional Chinese Medicine: Response Philosophy in Another Culture.
32733842 2020. Progress in the Research and Development of Anti-COVID-19 Drugs.
32733837 2020. A Perspective on Emerging Therapeutic Interventions for COVID-19.
32719766 2020. Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression.
32787684 2020. Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study.
32845164 2020. Phages in the fight against COVID-19?
32777281 2020. What underlies the benefit of famotidine formulations used during COVID-19?
32877709 2020. The New Foe and Old Friends: Are We Ready for Microbiota-based Therapeutics in Treating COVID-19 Patients?
32875166 2020. In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors.
32884603 2020. Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
32791978 2020. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
32771622 2020. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach.
32733775 2020. Ascorbate as Prophylaxis and Therapy for COVID-19-Update From Shanghai and U.S. Medical Institutions.
32861559 2020. Statins in COVID-19: A new ray of hope.
32754651 2020. SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
32869005 2020. A drug screening toolkit based on the -1 ribosomal frameshifting of SARS-CoV-2.
32802983 2020. Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin.
32802982 2020. Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz.
32802981 2020. Searching potential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking.
32802980 2020. Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space.
32725454 2020. Liver injury in remdesivir-treated COVID-19 patients.
32780299 2020. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
32840387 2020. Synthesis of N,N'-bis(1,5-dimethyl-2-phenyl-1,2-dihydro-3-oxopyrazol-4-yl) sebacamide that ameliorate osteoarthritis symptoms and improve bone marrow matrix structure and cartilage alterations induced by monoiodoacetate in the rat model: "Suggested potent anti-inflammatory agent against COVID-19".
32783919 2020. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
32681497 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
32695719 2020. Hydroxychloroquine in Dermatology and Beyond: Recent Update.
32837034 2020. Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19.
32837032 2020. Curcumin and Coagulopathy in the COVID19 Era.
32837035 2020. Snapshot of COVID-19 Related Clinical Trials in India.
32719218 2020. Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study.
32874008 2020. Indian perspective of remdesivir: A promising COVID-19 drug.
32825892 2020. White paper on Ivermectin as a potential therapy for COVID-19.
32757500 2020. Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.
32757497 2020. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication.
32869558 2020. Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence.
32835142 2020. Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?
32741372 2020. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
32880102 2020. Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study.
32740858 2020. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse.
32745811 2020. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.
32791240 2020. Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2.
32803479 2020. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.
32797326 2020. A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.
32835083 2020. Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors.
32835079 2020. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation.
32774508 2020. Chloroquine and COVID-19: Should We Care about Ototoxicity?

32795898 2020. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.
32795893 2020. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.
32795897 2020. Thymosin alpha1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
32862111 2020. Interferon beta-1b in treatment of severe COVID-19: A randomized clinical trial.
32862110 2020. Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.
32877828 2020. Immunotherapeutic approaches to curtail COVID-19.
32739476 2020. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
32738307 2020. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
32738306 2020. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
32738305 2020. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
32853675 2020. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
32853673 2020. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
32853672 2020. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
32777263 2020. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results.
32745548 2020. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
32853604 2020. Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2.
32760915 2020. Glucocorticoids save lives in COVID-19 patients.
32760206 2020. Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
32676542 2020. Insights into Potential Mechanisms of Injury and Treatment Targets in COVID-19, SARS-Cov-2 Infection.
32767379 2020. Biologic drugs during COVID-19 outbreak.
32756371 2020. BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study.
32801840 2020. A Review on Currently Available Potential Therapeutic Options for COVID-19.
32799596 2020. Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?
32745629 2020. A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19.
32738491 2020. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
32738490 2020. The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
32738483 2020. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
32726724 2020. Appropriate use of tocilizumab in COVID-19 infection.
32721534 2020. Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.
32721528 2020. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
32771630 2020. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
32768698 2020. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
32768697 2020. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.
32768693 2020. Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
32768701 2020. Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation.
32758689 2020. SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial.
32861824 2020. The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
32829047 2020. CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER.
32829044 2020. Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition.
32805422 2020. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
32798660 2020. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
32795605 2020. Nutritional status of patients with coronavirus disease 2019 (COVID-19).
32752138 2020. Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation.
32731361 2020. Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations.
32727145 2020. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
32718020 2020. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
32784899 2020. SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.
32756480 2020. COVID-19: The Immune Responses and Clinical Therapy Candidates.
32872332 2020. Delta9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
32825444 2020. Are Myths and Preconceptions Preventing us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?
32824985 2020. 4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
32824072 2020. New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine.
32823591 2020. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
32881350 2020. Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.
32840231 2020. Emerging Treatment Options of Regenerative Medicine in Severe Corona Virus/COVID 19 Infections.
32821175 2020. Hemoperfusion as a Supportive Treatment in a COVID-19 Patient with Late Pulmonary Thromboembolism: A Case Report.
32875426 2020. RNA interference as a promising treatment against SARS-CoV-2.
32864332 2021. Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis.
32874913 2020. Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial.
32837904 2020. Choose your shortcuts wisely: COVID-19 rapid reviews of traditional, complementary and integrative medicine.
32834994 2020. Integrative medicine for COVID-19: Researches and evidence.
32834993 2020. Clinical practice guidelines for COVID-19.
32834992 2020. Chinese medical drugs for coronavirus disease 2019: A systematic review and meta-analysis.
32817820 2020. Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study.
32802744 2020. Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19).
32766115 2020. Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19).
32766114 2020. Home-based traditional Chinese medicine nursing interventions for discharged patients with COVID-19: a rapid review of Chinese guidelines.
32742920 2020. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review.
32742919 2020. Is the traditional Chinese herb "Artemisia annua" possible to fight against COVID-19?
32727996 2020. Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
32863364 2020. Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion.
32812114 2020. Psychoactive compounds as multifactorial protection factors against COVID-19.
32801412 2020. The Rise and Fall in Therapeutic Candidates for COVID-19.
32818905 2020. ACE2, Metformin, and COVID-19.
32738617 2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.
32812725 2020. Hydroxychloroquine-related Rash in COVID-19 Infected Patient.
32812720 2020. Bacillus Calmette-Guerin (BCG) as a Protective Factor for COVID-19?
32812718 2020. Bacillus Calmette-Guerin vaccination Policy and Consumption of Ammonium Chloride-Enriched Confectioneries May Be Factors Reducing COVID-19 Death Rates in Europe.
32812340 2020. Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus.
32855101 2020. Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic.
32807723 2020. Effects of Probiotics in Conditions or Infections Similar to COVID-19 on Health Outcomes: An Evidence Analysis Center Scoping Review.
32792328 2020. Telehealth and Nutrition Support During the COVID-19 Pandemic.
32777318 2020. Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist.
32860913 2020. Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in psoriasis patients - A meta-estimate of pivotal phase 3 trials relevant to decision-making during the COVID-19 pandemic.
32766679 2020. Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
32750131 2020. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
32812039 2020. Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
32812025 2020. Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
32782662 2020. Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID-19: Quantification and precautions for a busy clinician.
32843231 2020. High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
32837100 2020. An Ayurvedic Perspective along with in Silico Study of the Drugs for the Management of Sars-Cov-2.
32863675 2020. Principles of Rajayakshma management for COVID-19.
32837101 2020. Immunity Against COVID-19: Potential Role of Ayush Kwath.
32802787 2020. Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.
32741313 2020. Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2.
32713863 2020. Computational search for potential COVID-19 drugs from FDAapproved drugs and small molecules of natural origin identifies several anti-virals and plant products.
32877501 2020. Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function.